Results 201 to 210 of about 50,558 (217)

Ritonavir

Drugs, 2012
Diana Faulds, Andrew P Lea, D Faulds
exaly  

Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir

European Journal of Clinical Pharmacology, 2010
Teijo I Saari, Pertti J. Neuvonen, Kari Laine   +2 more
exaly  

Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma

European Journal of Cancer, 2020
Ashar Ahmad, Laurel Rauschenbach, Sied Kebir   +2 more
exaly  

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet, The, 2020
Edmund Juszczak, Lucy Chappell, Martin Landray   +2 more
exaly  

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

Lancet, The, 2008
Jean-Michel Molina, Jaime F Andrade-Villanueva, Graeme Moyle   +2 more
exaly  

Ritonavir-boosted protease inhibitors in HIV therapy

Annals of Medicine, 2011
Mark Hull
exaly  

Ritonavir: An Extraordinary Example of Conformational Polymorphism

Pharmaceutical Research, 2001
R Henry
exaly  

Ritonavir

2021
openaire   +1 more source

Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers

British Journal of Clinical Pharmacology, 1998
Ann Hsu, J M Leonard, G R Granneman
exaly  

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV-1-infected patients

British Journal of Clinical Pharmacology, 2005
Jos Beijnen, A D R Huitema, P L Meenhorst   +2 more
exaly